102 related articles for article (PubMed ID: 5338956)
21. [Trial of a new leprostatics (B-663) in the treatment of lepromatous leprosy].
Renders A
Ann Soc Belges Med Trop Parasitol Mycol; 1968; 48(6):625-35. PubMed ID: 5759964
[No Abstract] [Full Text] [Related]
22. The use of B 663 (clofazimine) in the treatment of Chinese leprosy patients with chronic reaction.
Warren AG
Lepr Rev; 1970 Apr; 41(2):74-82. PubMed ID: 5453082
[No Abstract] [Full Text] [Related]
23. Treatment of leprosy with a phenazine derivative (B 663 or G 30 320)--clofazimine.
Gatti JC; Cardama JE; Balina LM; Crespi HG; Bianchi O; Santabaya E; Farina MH
Lepr Rev; 1970 Apr; 41(2):89-92. PubMed ID: 5453084
[No Abstract] [Full Text] [Related]
24. New drug for leprosy.
Br Med J; 1969 Mar; 1(5647):797-8. PubMed ID: 5774074
[No Abstract] [Full Text] [Related]
25. Erythema nodosum leprosum.
Browne SG
Int J Lepr Other Mycobact Dis; 1967; 35(3):395-7. PubMed ID: 5630360
[No Abstract] [Full Text] [Related]
26. Chemotherapy of leprosy.
Leiker DL
Int J Lepr Other Mycobact Dis; 1971; 39(2):462-6. PubMed ID: 4948084
[No Abstract] [Full Text] [Related]
27. Clofazimine in leprosy.
Schulz EJ
Br Med J; 1972 Mar; 1(5802):749. PubMed ID: 5015339
[No Abstract] [Full Text] [Related]
28. Clinical evaluation of Lamprene (Geigy). A preliminary report.
Karuru ER
Lepr Rev; 1970 Apr; 41(2):83-8. PubMed ID: 5453083
[No Abstract] [Full Text] [Related]
29. Management of neuritis in leprosy.
Pfaltzgraff RE
Trop Doct; 1973 Jul; 3(3):138-9. PubMed ID: 4715065
[No Abstract] [Full Text] [Related]
30. A preliminary report on the use of B663 in the treatment of Chinese leprosy patients with chronic reaction.
Warren AG
Lepr Rev; 1968 Apr; 39(2):61-6. PubMed ID: 5653308
[No Abstract] [Full Text] [Related]
31. Management of steroid-dependency with clofazimine (Lamprene or B 663 (Geigy)).
Morgan J
Lepr Rev; 1970 Oct; 41(4):229-32. PubMed ID: 5515679
[No Abstract] [Full Text] [Related]
32. A study of skin pigmentation by clofazimine.
Levy L; Randall HP
Int J Lepr Other Mycobact Dis; 1970; 38(4):404-16. PubMed ID: 5534493
[No Abstract] [Full Text] [Related]
33. [Action of B663 on obstinate reactogenic forms of Hansen's disease].
Rostant MM
Bord Med; 1970 Apr; 3(4):1033-4 passim. PubMed ID: 5422391
[No Abstract] [Full Text] [Related]
34. [Experimental studies in man on hyaluronidase inhibiting effect of clofazimine].
Mathies H; Ress U
Arzneimittelforschung; 1970 Dec; 20(12):1838-40. PubMed ID: 5537076
[No Abstract] [Full Text] [Related]
35. Phagocytosis-promoting effect of clofazimine (B 663) in patients with subnormal granulocyte function.
Brandt L
Scand J Haematol; 1971; 8(5):400-4. PubMed ID: 5289696
[No Abstract] [Full Text] [Related]
36. Activity of phenazine analogs against Mycobacterium leprae infections in mice.
Van Landingham RM; Walker LL; O'Sullivan JF; Shinnick TM
Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):406-14. PubMed ID: 8228439
[TBL] [Abstract][Full Text] [Related]
37. [Use of frenolon in the treatment of psychoses].
Kubacki A; Ojrzyńska B
Psychiatr Pol; 1967; 1(3):295-300. PubMed ID: 5593257
[No Abstract] [Full Text] [Related]
38. Comparative cytomorphology of skin, lymph node, liver and bone marrow in patients with lepromatous leprosy.
Singh N; Bhatia A; Lakra A; Arora VK; Bhattacharya SN
Cytopathology; 2006 Oct; 17(5):257-61. PubMed ID: 16961654
[TBL] [Abstract][Full Text] [Related]
39. Sural nerve biopsy in leprosy patients after varying periods of treatment: histopathological and bacteriological findings on light microscopy.
Haimanot RT; Mshana RN; McDougall AC; Andersen JG
Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):163-70. PubMed ID: 6539309
[TBL] [Abstract][Full Text] [Related]
40. [Relapses after multibacillary leprosy treatment].
Rodríguez G; Pinto R; Laverde C; Sarmiento M; Riveros A; Valderrama J; Ordóñez N
Biomedica; 2004 Jun; 24(2):133-9. PubMed ID: 15495593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
